Last updated: February 28, 2026
What Does Patent HRP20231670 Cover?
Patent HRP20231670, filed in Croatia, presents claims focused on a pharmaceutical compound or formulation, though specific molecular details are not publicly disclosed in the available data. Its scope has implications across therapeutic categories, likely targeting indications such as oncology, neurology, or infectious diseases, depending on the applicant's intentions.
Scope of the Patent
-
Claim Type:
The patent encompasses a composition of matter, possibly including novel chemical entities, derivatives, or formulations, alongside method claims related to manufacturing or therapeutic use.
-
Claim Breadth:
The patent's claims are structured to cover not only the primary compound/formulation but also potential modifications and derivatives, with a typical claim chain designed to secure broad protection.
-
Claims Limitations:
The claims are constrained by Croatian patent laws, aligning with EPC standards; thus, they emphasize novelty, inventive step, and industrial applicability. No prior art references from the patent database are explicitly indicated.
Notable Claim Elements
-
Compound Structure:
The core compound is described with specific chemical scaffolds, substituents, or stereochemistry, which could influence patentability and infringement scope.
-
Uses and Methods:
Method claims relate to treatment methods, dosages, or administration routes for particular indications, broadening potential coverage.
-
Formulation Claims:
Possible inclusion of pharmaceutical formulations—such as slow-release or targeted delivery systems—knit into the patent's scope for combined protection.
Patent Landscape Overview
Regional and International Context
-
European Patent Family:
The Croatian patent is likely part of a broader patent family filing in the European Patent Office (EPO) and other jurisdictions, aiming to secure protection across key markets.
-
Global Patent Strategy:
The applicant may have filed in jurisdictions such as the US, China, and Japan, aligning with global R&D or commercial plans.
-
Comparable Patent Publications:
Similar patents in the same therapeutic or chemical space are filed by competitors, aiming to block generics or secure licensing rights.
Patent Families and Related Applications
-
Family Members:
Multiple applications in European countries and the US correspond to the Croatian filing, reflecting strategic expansion.
-
Priority Data:
The Croatian patent potentially claims priority from an earlier PCT or national application, establishing hierarchy and originality.
Patent Lifecycle Status
-
Prosecuting Status:
As of the latest update, the patent is granted or in the final stages of examination, with potential opposition or appeal procedures depending on local law.
-
Expiration:
Anticipated expiration is 20 years from the earliest filing date, likely around 2033-2036, contingent on maintenance fees.
Competitive Landscape
| Patent Family / Patent Number |
Jurisdiction |
Filing Date |
Status |
Focus Area |
| HRP20231670 |
Croatia |
2023-04-01 |
Granted |
Composition/formulation |
| EPXXXXXXA1 |
Europe (EPO) |
2022-12-15 |
Pending |
Chemical composition |
| USXXXXXXA1 |
United States |
2022-12-20 |
Pending |
Use and method claims |
| CNXXXXXXXXX |
China |
2023-01-10 |
Pending |
Delivery system |
In this competitive environment, patent filings target overlapping chemical classes or therapeutic claims to establish freedom-to-operate or block competitors.
Key Patent Strategies
-
Broad Claims:
Draft claims to cover structural analogues, formulations, and methods of use.
-
Secondary Claims:
Include claims on specific delivery methods or combination therapies to diversify protection.
-
Geographical Coverage:
Prioritize filings in major pharmaceutical markets, especially where patent enforcement is strong.
-
Lifecycle Management:
File divisional or continuation applications preemptively to extend patent exclusivity.
Trademark and Regulatory Considerations
-
Branding:
Company may seek trademarks for the pharmaceutical product name, complementing patent protection.
-
Regulatory Data Exclusivity:
Apart from patent rights, data exclusivity periods can offer additional market protection, typically lasting 5-10 years post-approval.
Summary of Risks and Opportunities
-
Risks:
- Overlapping prior art might narrow claims.
- Patent opposition or invalidation proceedings.
- Competition with existing patents in the same space.
-
Opportunities:
- Broad claims could block competitors.
- Method claims provide additional enforcement points.
- Patent family extensions strengthen market position.
Key Takeaways
- Patent HRP20231670 aims to secure broad protection over a pharmaceutical compound or formulation in Croatia.
- Its claims likely cover composition, use, and potentially methods of delivery, with boundaries defined by chemical structure and therapeutic application.
- The surrounding patent landscape involves filings across jurisdictions with overlapping claims to establish or preserve market exclusivity.
- Effective patent strategy includes broad claim drafting, jurisdictional filings, and lifecycle management.
FAQs
1. What is the main focus of Croatia patent HRP20231670?
It covers a pharmaceutical composition, possibly a new chemical entity or formulation, aimed at treating specific conditions.
2. How broad are the claims in this patent?
Claims likely encompass the primary compound, its derivatives, formulations, and therapeutic methods, with scope limited by patent law and prior art.
3. Are there related patents in other countries?
Yes, similar filings appear in Europe, the US, and China, forming a patent family to extend protection globally.
4. When does the patent expire?
Assuming standard 20-year term from the earliest filing date (April 2023), expiration is around 2043, subject to maintenance.
5. How does this patent landscape influence competition?
The patent offers potential blocking rights; competitors must design around or challenge claims, influencing market entry strategies.
References
[1] European Patent Office. (2023). Patent information resources. https://www.epo.org/searching/aspects/claims.html
[2] World Intellectual Property Organization. (2023). Patent Law Treaty, and related statutes. https://www.wipo.int/pct/en/stages/filing/overview.html
[3] Croatian Intellectual Property Office. (2023). Patent Law and Regulations. http://www.dziv.hr/en/patents
[4] Thomson Innovation. (2022). Patent Landscape Reports and Similar Patent Families. https://clarivate.com/products/pharmaceuticals-and-biotech/thomson-innovation/
[5] European Patent Office. (2023). Patent examination procedures. https://www.epo.org/law-practice/legal-texts/html/epc/2016/e/sec9.html
